UBS Oconnor LLC
- SEC CIK
- 0001132716
- Latest filing
- Aug 14, 2026
PCVX holding history
Vaxcyte, Inc. in every 13F filed by UBS Oconnor LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PCVX overviewAll 13F holders of PCVXFull Q4 2025 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q1 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −5,307−100.0% | Sold out | Holders |
| Q3 2024 | 5,307 | $606.4K | <0.1% | −1,000−15.9% | Reduced | Holders |
| Q2 2024 | 6,307 | $476.2K | <0.1% | +300+5.0% | Added | Holders |
| Q1 2024 | 6,007 | $410.3K | <0.1% | −2,023−25.2% | Reduced | Holders |
| Q4 2023 | 8,030 | $504.3K | <0.1% | −1,970−19.7% | Reduced | Holders |
| Q3 2023 | 10,000 | $509.8K | <0.1% | +10,000 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −8,071−100.0% | Sold out | Holders |
| Q1 2023 | 8,071 | $302.5K | <0.1% | +8,071 | New | Holders |